Skip to main content
Caplight Logo









MI:RNA

MI:RNA

Private
DundeeHealthcare & Life Scienceshttps://mirna.tech/

Last Round

Series A

Extension

Dec 10, 2025

Total Funding Raised

$7.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MI:RNA is a veterinary diagnostics company that develops a platform using microRNA biomarkers and artificial intelligence for early disease detection in animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

veterinary diagnosticsmicroRNAmiRNAveterinary biotechnologyearly disease detectionbiomarker profilingvet techanimal health diagnosticspredictive diagnosticsdiagnostic platformAI diagnosticsveterinary lab servicesprecision medicinecompanion animal healthnon-invasive testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MI:RNA Comparables

Compare MI:RNA with similar companies based on industry and business-model similarity.

MI:RNA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Acuvet Biotech
71%
Mars, Incorporated
70%
Moichor
68%

MI:RNA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 10, 2025
GrantOct 14, 2025
Series AJul 3, 2024

MI:RNA Investors

Notable investors and investment history

MI:RNA investors
InvestorRounds
Digitalis VenturesSeries A
Veterinary Angel Network for EntrepreneursSeries A, Series A Extension
Gabriel Investments LtdSeries A, Series A Extension, Seed
Equity GapSeries A, Series A Extension, Seed
Ani.VCSeries A Extension
Animal Health AngelsSeries A, Series A Extension
NovaQuest Capital ManagementSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2026

    Grew 15% QoQ, from 26 to 30 employees.

  • Feb 9, 2026

    Grew 17% QoQ, from 24 to 28 employees.

MI:RNA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MI:RNA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MI:RNA's valuation, stock price, and market status.

Firmographic Details

HeadquartersDundee
Employee Range30
Year Founded2019
Last FundingDec 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?